Panel hears primer on how health-care dollars flow and limits of state regulation

At a March meeting of the House Health Care Committee, an invited presenter gave an overview of how money moves through the health-care system and outlined the practical limits on what state regulators can change.

The presenter said the U.S. system differs from a classic market because of imperfect information, concentrated provider markets and widespread third‑party payers — entities that pay for care other than the patient — and urged the committee to focus on which regulatory levers actually affect different parts of the system.

The presenter opened with a widely used finding: a small fraction of patients account for the majority of spending. “Imagine Vermonters lined up from the least expensive to the most expensive. The most expensive 10% are somewhere between two‑thirds and three‑quarters of all health‑care spending,” the presenter said, describing examples such as very premature infants and complex cancer care.

Why it matters: that concentration means pooled payment systems are essential to finance catastrophic care, and it also limits what price‑ or transparency‑based reforms can achieve unless paired with quality measures.

The briefing described three broad payer types and how each constrains state action. Private insurers collect premiums; employers may be fully or partly self‑insured (the presenter said roughly 200,000 Vermonters work for self‑insured employers). Federal entitlement programs —…